PRCT — PROCEPT BioRobotics Corporation

PRCT closed at $19.80 (-0.15%) on Oct 27, 2026. Float: 53.8M shares. Latest SEC filing: 8-K on Oct 2, 2026.

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Chart, dilution, float and news for PRCT in the TickerWise workspace.

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.

Company profile

• Sector: Healthcare
• Industry: Medical - Devices
• Country: US
• Exchange: NASDAQ
• Employees: 756
• Website: https://www.procept-biorobotics.com

Latest SEC filings for PRCT

• 2026-10-028-K
• 2026-09-248-K
• 2026-08-0510-Q
• 2026-08-048-K
• 2026-06-108-K
• 2026-06-01SD
• 2026-05-18SCHEDULE 13G/A
• 2026-04-3010-Q
• 2026-04-298-K
• 2026-03-06SCHEDULE 13G/A

Latest PRCT news

• 2026-10-28PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Read article
• 2026-10-28Important Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Planet Fitness, Inc. (NYSE: PLNT); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is Investigating Claims on Your Behalf Read article
• 2026-10-12PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026 Read article
• 2026-10-01PROCEPT BioRobotics (NASDAQ: PRCT) Investors: Securities Class Action Filed; Shareholders Should Contact Shareholders Foundation Read article
• 2026-09-30LAWSUIT ALERT: Investors who lost money with PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares should contact the Shareholders Foundation Read article

Related companies

• ABT — Abbott Laboratories
• SYK — Stryker Corporation
• MDT — Medtronic plc
• BSX — Boston Scientific Corporation
• EW — Edwards Lifesciences Corporation
• PHG — Koninklijke Philips N.V.
• DXCM — DexCom, Inc.
• STE — STERIS plc

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Educational tool only — not investment advice.